J Mensa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Mensa

Showing results (251-260 of 253) with videos related to

Pageof 26

Sort By:

You have reached the last page of results.This site can display upto 253 results.

The New England Journal of Medicine|January 18, 2023

Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 YearsPatricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 8, 2021

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infectionE Moreno-García, E Rico, L Albiach, et al.

The New England Journal of Medicine|January 25, 2018

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.

Pageof 26

Search research articles

Showing results (251-260 of 253) with videos related to

Sort By:

Pageof 26

You have reached the last page of results.This site can display upto 253 results.

The New England Journal of Medicine|January 18, 2023

Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 YearsPatricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 8, 2021

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infectionE Moreno-García, E Rico, L Albiach, et al.

The New England Journal of Medicine|January 25, 2018

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.

Pageof 26